Management of Innovation in Academia: A Case Study in Tampere
Open Access
- 1 July 2015
- journal article
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Journal of technology management & innovation
- Vol. 10 (2) , 198-210
Abstract
Universities have an active role in research commercialisation and hence, many universities have established a technology transfer office. However, technology transfer happens too early in most of the cases and commercial potential of innovation is not clear yet. Proof of Concept, which is developed in the university, is suggested to be a solution for this. In this single case study, Proof of Concept development and technology transfer in the regenerative medicine sector are studied in Tampere, Finland. It was shown how Proof of Concepts are nurtured alongside the research in the faculty. However, sufficient funding and market understanding is needed in order to develop a Proof of Concept that is possible to transfer to industry.Keywords
This publication has 12 references indexed in Scilit:
- Market challenges facing academic research in commercializing nano-enabled implantable devices for in-vivo biomedical analysisTechnovation, 2012
- An evolutionary perspective on health innovation systemsJournal of Evolutionary Economics, 2008
- Invention, innovation, entrepreneurship in academic medical centersSurgery, 2008
- Out of sight: problem sequences and epistemic boundaries of medical know-how on glaucomaJournal of Evolutionary Economics, 2007
- The University and the Start-Up: Lessons from the Past Two Decades2005
- Valleys of Death and Darwinian Seas: Financing the Invention to Innovation Transition in the United StatesThe Journal of Technology Transfer, 2003
- Uncertainty and Technological Change in MedicineJournal of Health Politics, Policy and Law, 2001
- Proofs and Prototypes for Sale: The Licensing of University InventionsAmerican Economic Review, 2001
- Star scientists and institutional transformation: Patterns of invention and innovation in the formation of the biotechnology industryProceedings of the National Academy of Sciences, 1996
- The Dynamics of Technological Change in MedicineHealth Affairs, 1994